ArticleMayo Clinic proceedings2025
Estimating the Burden of Undiagnosed Heart Failure With Preserved Ejection Fraction and Sleep Abnormalities in the Community.
Article in Mayo Clinic proceedings, 2025. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 1 paper.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
1 citing paper in PubMed.
- Implications of Potential Undiagnosed HFpEF on Symptomatic Response With Coronary Revascularization.JACC. Heart failure · 2026Article
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
7 authors.
Funding
Abstract
objectiveTo determine the co-prevalence of heart failure with preserved ejection fraction (HFpEF) and sleep abnormalities in the community. PATIENTS AND
methodsWe performed a cross-sectional symptom survey of Sleep Number Company smart bed users with continuous physiological monitoring in the United States. We computed HFpEF probability using the validated HFpEF-ABA (Age, Body Mass Index, and History of Atrial Fibrillation) algorithm, collected symptoms surveys, and measured 5 weeks of sleep data to estimate the prevalence of undiagnosed HFpEF and association with sleep abnormalities between April 1 to May 9, 2023.
resultsSix thousand sixty-four, individuals completed the symptom survey (median age, 53 years [Q1-Q3: 43-63 years], median body mass index 29.3 kg/m
conclusionNearly 1 in 10 smart bed users across the United States have dyspnea and HFpEF-ABA probability scores suggesting potentially undiagnosed HFpEF with multiple sleep abnormalities. The role of ABA-based community screening for HFpEF and sleep abnormalities requires further study.
Indexed as
Identifiers
What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.